Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 13431-13440 of 13618

Page
per page
  1. Quinoclamine
    C6927 Quinoclamine
    Summary: A naphthoquinone derivative with antitumor and NF-κB pathway inhibitory activity
      ≥38.7 mg/mL
  2. Chelidonic acid
    C7060 Chelidonic acid
    Summary: A natural acidic compound with antibacterial, anti-inflammatory and glutamate decarboxylase inhibitory activities
      ≥34.4 mg/mL
  3. Hodostin
    C7074 Hodostin
    Summary: A reversible acetylcholinesterase inhibitor acting on the peripheral nervous system
      ≥46.6 mg/mL
  4. Hydroxylammonium chloride
    C7080 Hydroxylammonium chloride
    Summary: A selective MAO inhibitor that inhibits platelet aggregation and an organic synthesis intermediate
      ≥10.6 mg/mL
  5. Pralidoxime chloride
    C7193 Pralidoxime chloride
    Summary: An acetylcholinesterase reactivator for acute organophosphate poisoning
      ≥6.34 mg/mL
  6. Fmoc-His(Boc)-OH.CHA
    A6621 Fmoc-His(Boc)-OH.CHA
      ≥51.9 mg/mL
  7. Solifenacin hydrochloride
    B3415 Solifenacin hydrochloride
    Summary: muscarinic receptor antagonist
      ≥50 mg/mL
  8. Ferrostatin-1 (Fer-1)
    A4371 Ferrostatin-1 (Fer-1)
     87 Citation
    Target: Ferroptosis
    Summary: ferroptosis inhibitor
      ≥149 mg/mL
  9. Tepotinib
    A3388 Tepotinib
     1 Citation
    Target: c-MET
    Summary: An oral c-MET (MET) tyrosine kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.93 mg/mL
  10. H-1152
    A3457 H-1152
    Summary: H-1152 is a membrane permeable, selective inhibitor.

Items 13431-13440 of 13618

Page
per page